Information
Asclemed USA Inc. Recalls Lidolog Kit
This is a Class III recall. This product is unlikely to cause adverse health reactions but violates FDA regulations.
Source: FDA
InfoRecall #D-0713-2026Drug / Pharmaceutical
Asclemed USA Inc. Recalls Lidolog Kit
Asclemed USA Inc. · Class III — Regulatory
Product Description
Lidolog Kit, Kit Contains: Lidocaine HCl Injection, USP, 2% (2mL) vial, 1 Dose, Single use Only, Rx Only, Distributed by: Enovachem Pharmaceuticals, Torrance, CA 90501, NDC: 76420-760-01.
Reason for Recall
Labeling: Not Elsewhere Classified: The label wrap covers the barcode, making it hard to scan
FDA Classification
Class III — Regulatory
A situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
Distribution
Within U.S. - Tennessee
Remedy
Consumers should stop using this product. Contact the recalling firm for further instructions regarding this product.
411 Press Analysis
Asclemed USA Inc. initiated a Class III recall of a pharmaceutical product on July 15, 2026 affecting 18 kits. Labeling: Not Elsewhere Classified: The label wrap covers the barcode, making it hard to scan. Class III recalls involve products that are unlikely to cause adverse health reactions but violate FDA regulations. The product was distributed in Tennessee. Consumers may continue monitoring FDA updates regarding this recall.
Sources: FDA openFDA Enforcement Database
This recall appears in: Drug & Medication Defects.